Paper

EPCO-20. DEVELOPMENT OF A NETWORK-DERIVED PREDICTIVE BIOMARKER FOR PRMT5 INHIBITOR RESPONSE IN IDH1-MUTANT HIGH-GRADE GLIOMA PATIENTS

Neuro-Oncology · 2025 · Zhiqiang Li, Aviva G Beckmann, Qi Pan et al.